TrialResults-center.org

Menu

Taselisib Phosphoinositide 3-kinase inhibitor

Advanced breast cancer (metastatic)

All type of patients: 1 trials - SANDPIPER

taselisib + fulvestrant vs fulvestrant alone

No demonstrated result

Endpoint	TE [95% CI]	p val	I2	n	k	trials

TE: treatment effect; CI: confidence interval; k: nulmber of trials; n: total number of patients

Modal title

- About - Browse pathology | treatment - Site map - Credits Made with in Lyon - Contact us - Privacy policy -